{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T14:06:57Z","timestamp":1777298817933,"version":"3.51.4"},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["canadianjournalofophthalmology.ca","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Ophthalmology"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.jcjo.2021.02.028","type":"journal-article","created":{"date-parts":[[2021,3,13]],"date-time":"2021-03-13T15:08:33Z","timestamp":1615648113000},"page":"118-126","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Reversible HER2 antibody-drug conjugate\u2013induced ocular toxicity"],"prefix":"10.1016","volume":"57","author":[{"given":"Anushree","family":"Sharma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1090-5025","authenticated-orcid":false,"given":"Kamran M.","family":"Riaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0299-3347","authenticated-orcid":false,"given":"Mohsain S.","family":"Gill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amita","family":"Patnaik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7234-2283","authenticated-orcid":false,"given":"Susanna V.","family":"Ulahannan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4789-4913","authenticated-orcid":false,"given":"Judy S.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan S.","family":"Gombos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiuqing","family":"Ang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dragan","family":"Cicic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory R.","family":"Bergonio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara M.","family":"Wirostko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcjo.2021.02.028_bib0001","doi-asserted-by":"crossref","DOI":"10.1126\/science.1260419","article-title":"Tissue-based map of the human proteome","volume":"347","author":"Uhlen","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.jcjo.2021.02.028_bib0002","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1634\/theoncologist.2013-0217","article-title":"HER story: the next chapter in HER-2-directed therapy for advanced breast cancer","volume":"18","author":"Verma","year":"2013","journal-title":"Oncologist"},{"key":"10.1016\/j.jcjo.2021.02.028_bib0003","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nrd.2016.268","article-title":"Strategies and challenges for the next generation of antibody\u2013drug conjugates","volume":"16","author":"Beck","year":"2017","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jcjo.2021.02.028_bib0004","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1089\/jop.2015.0064","article-title":"Ocular adverse events associated with antibody\u2013drug conjugates in human clinical trials","volume":"31","author":"Eaton","year":"2015","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.jcjo.2021.02.028_bib0005","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1186\/s12885-015-1969-3","article-title":"Trastuzumab-induced corneal ulceration: successful no-drug treatment of a \u201cblind\u201d side effect in a case report","volume":"15","author":"Orlandi","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jcjo.2021.02.028_bib0006","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s10549-019-05179-y","article-title":"Corneal features in trastuzumab emtansine treatment: not a rare occurrence","volume":"175","author":"Deklerck","year":"2019","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.jcjo.2021.02.028_bib0007","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/00003226-200101000-00016","article-title":"Expression of the receptor tyrosine kinases, epidermal growth factor receptor, ErbB2, and ErbB3, in human ocular surface epithelia","volume":"20","author":"Liu","year":"2001","journal-title":"Cornea"},{"key":"10.1016\/j.jcjo.2021.02.028_bib0008","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1016\/j.ophtha.2014.04.025","article-title":"Medically reversible limbal stem cell disease: clinical features and management strategies","volume":"121","author":"Kim","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2021.02.028_bib0009","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.transci.2017.07.023","article-title":"Blood derived eye drops for the treatment of cornea and ocular surface disease","volume":"56","author":"Giannaccare","year":"2017","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.jcjo.2021.02.028_bib0010","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1136\/bjo.66.11.705","article-title":"Corticosteroids and corneal epithelial wound healing","volume":"66","author":"Petroutsos","year":"1982","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jcjo.2021.02.028_bib0011","article-title":"Autologous serum eye drops for dry eye","volume":"2","author":"Pan","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jcjo.2021.02.028_bib0012","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/art.1780270415","article-title":"Beneficial effect of artificial tears made with autologous serum in patients with keratoconjunctivitis sicca","volume":"27","author":"Fox","year":"1984","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jcjo.2021.02.028_bib0013","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.3390\/ijms20051115","article-title":"HER2 directed antibody-drug-conjugates beyond T-DM1 in breast cancer","volume":"20","author":"Rinnerthaler","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jcjo.2021.02.028_bib0014","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1007\/s00417-004-1106-5","article-title":"An optimised protocol for the production of autologous serum eyedrops","volume":"243","author":"Liu","year":"2005","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.jcjo.2021.02.028_bib0015","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1590\/S0004-27492008000700010","article-title":"Autologous serum for ocular surface diseases","volume":"71","author":"Quinto","year":"2008","journal-title":"Arq Bras Oftalmol"},{"key":"10.1016\/j.jcjo.2021.02.028_bib0016","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/ICO.0000000000001820","article-title":"Global consensus on definition, classification, diagnosis, and staging of limbal stem cell deficiency","volume":"38","author":"Deng","year":"2019","journal-title":"Cornea"},{"key":"10.1016\/j.jcjo.2021.02.028_bib0017","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/229560a0","article-title":"Role of the pericorneal papillary structure in renewal of corneal epithelium","volume":"229","author":"Davanger","year":"1971","journal-title":"Nature"},{"key":"10.1016\/j.jcjo.2021.02.028_bib0018","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.exer.2003.09.008","article-title":"Corneal epithelial stem cells at the limbus: looking at some old problems from a new angle","volume":"78","author":"Lavker","year":"2004","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.jcjo.2021.02.028_bib0019","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1001\/archopht.1961.01840020697016","article-title":"Cell turnover in the adult human eye","volume":"65","author":"Hanna","year":"1961","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jcjo.2021.02.028_bib0020","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1089\/scd.2012.0180","article-title":"The key role of insulin-like growth factor I in limbal stem cell differentiation and the corneal wound-healing process","volume":"21","author":"Trosan","year":"2012","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.jcjo.2021.02.028_bib0021","first-page":"1346","article-title":"Activation of epidermal growth factor receptor during corneal epithelial migration","volume":"41","author":"Zieske","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jcjo.2021.02.028_bib0022","first-page":"155","article-title":"Limbal palisades of Vogt","volume":"80","author":"Goldberg","year":"1982","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.jcjo.2021.02.028_bib0023","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.1167\/iovs.04-0119","article-title":"Role of ErbB2 in corneal epithelial wound healing","volume":"45","author":"Xu","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jcjo.2021.02.028_bib0024","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jtos.2017.11.002","article-title":"The diagnosis of limbal stem cell deficiency","volume":"16","author":"Le","year":"2018","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jcjo.2021.02.028_bib0025","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0161-6420(89)32833-8","article-title":"Limbal autograft transplantation for ocular surface disorders","volume":"96","author":"Kenyon","year":"1989","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2021.02.028_bib0026","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.survophthal.2016.11.008","article-title":"Drug-induced corneal epithelial changes","volume":"62","author":"Raizman","year":"2017","journal-title":"Surv Ophthalmol"}],"container-title":["Canadian Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008418221000776?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008418221000776?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T20:09:59Z","timestamp":1757794199000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008418221000776"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S0008418221000776"],"URL":"https:\/\/doi.org\/10.1016\/j.jcjo.2021.02.028","relation":{},"ISSN":["0008-4182"],"issn-type":[{"value":"0008-4182","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reversible HER2 antibody-drug conjugate\u2013induced ocular toxicity","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcjo.2021.02.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Canadian Ophthalmological Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}